Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × pomalidomide × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 79 Recurrence 17 Neoplasms 7 Neoplasms, Plasma Cell 3 Lymphoma, Non-Hodgkin 3 Sarcoma, Kaposi 2 Leukemia, Myeloid, Acute 2 Immunoglobulin Light-chain Amyloidosis 2 Hematologic Neoplasms 2 Chromosome 17 deletion 2 Acquired Immunodeficiency Syndrome 2 Waldenstrom Macroglobulinemia 1 Smoldering Multiple Myeloma 1 Proteostasis Deficiencies 1 Plasmacytoma 1 Plasmablastic Lymphoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Hodgkin Disease 1 Epstein-Barr Virus Infections 1 Burkitt Lymphoma 1 Alzheimer Disease 1

Interventions

ruxolitinib 8 bomedemstat 3 Specimen Handling 3 Biopsy 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Injections 2 Cyclophosphamide 2 venetoclax 1 veliparib 1 poly ICLC 1 piperine 1 pevonedistat 1 iadademstat 1 givinostat hydrochloride 1 givinostat 1 fludarabine 1 fedratinib 1 demethoxycurcumin 1 decitabine and cedazuridine drug combination 1 anagrelide 1 X-Rays 1 Valganciclovir 1 Topotecan 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡